Endothelial PD-L1 Expression as a Biomarker for Acute Rejection in Heart Transplantation

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2018.07.064
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated With Checkpoint Blockade

Cancer immunology research
Cancer ResearchImmunology
2017English

QTc Prolongation May Be a Late Biomarker of Orthotopic Heart Transplantation (OHT) Rejection

Journal of Electrocardiology
Cardiovascular MedicineCardiology
2016English

ARID1A Alterations Function as a Biomarker for Longer Progression-Free Survival After Anti-Pd-1/Pd-L1 Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Expression of PD-1, PD-L1, and PD-L2 in Posttransplant Lymphoproliferative Disorder After Solid Organ Transplantation

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2018English

PD-L1 Expression Combined With Microsatellite Instability/Cd8+ Tumor Infiltrating Lymphocytes as a Useful Prognostic Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2019English

Heat Shock Protein 90α Is a Potential Serological Biomarker of Acute Rejection After Renal Transplantation

PLoS ONE
Multidisciplinary
2016English

PD-L1 Expression in Inflammatory Myofibroblastic Tumors

Modern Pathology
Forensic MedicinePathology
2018English

P2.01-90 PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small Cell Lung Cancer Patients With or Without EGFR Mutation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Metabolomics Identifies Metabolite Biomarkers Associated With Acute Rejection After Heart Transplantation in Rats

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy